The key findings of this report [1] are:

• The bioinformatics market is forecast to grow at a CAGR of 23% to $4.5bn by 2011, from a value of $1.6bn in 2006. The US led the geographical market with a share of 45% in 2006, but Europe’s CAGR of 24.6% will narrow the gap over the forecast period.
• Bioinformatics-enabled protein biomarker discovery will enable the development of safer and more effective drugs, targeted therapies and molecular diagnostics.
• Systems biology modelling is forecast to grow at a rate of 35% over the next five years, the highest growth of any bioinformatics sector. The potential for widespread integration throughout all stages of drug discovery will act as a catalyst for this expansion.
• Knowledge management is currently the leading bioinformatics market segment. This lead will be strengthened by mass adoption of Semantic Web technology and the increasing availability of software through the internet.
• Software for next-generation sequencing has vastly reduced time and cost constraints of DNA-sequencing. The miniaturization of reactions has increased their quality and density, subsequently lowering per-reaction costs.